Your browser doesn't support javascript.
loading
SGLT-2 Inhibitors and GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease.
Sajja, Aparna P; Dey, Amit K; Guha, Avirup; Elnabawi, Youssef; Joshi, Aditya A; Kalra, Ankur.
Afiliación
  • Sajja AP; 1 Department of Internal Medicine, Johns Hopkins University Medical Center, Baltimore, MD, USA.
  • Dey AK; 2 Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Guha A; 3 Division of Cardiovascular Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Elnabawi Y; 2 Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Joshi AA; 2 Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Kalra A; 3 Division of Cardiovascular Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
J Cardiovasc Pharmacol Ther ; 24(5): 422-427, 2019 09.
Article en En | MEDLINE | ID: mdl-31064213

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glucemia / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Incretinas / Receptor del Péptido 1 Similar al Glucagón / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Idioma: En Revista: J Cardiovasc Pharmacol Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / FARMACOLOGIA Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glucemia / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Incretinas / Receptor del Péptido 1 Similar al Glucagón / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Idioma: En Revista: J Cardiovasc Pharmacol Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / FARMACOLOGIA Año: 2019 Tipo del documento: Article